pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 718 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
mebendazole
Emverm (mebendazole)
Ancylostomiasis (Hookworm Infections)
$AMRXAmneal Pharmaceuticals, Inc.
0 catalysts
Marketed
mefloquine hydrochloride
Mefloquine Hydrochloride (mefloquine hydrochloride)
Malaria
Barr Laboratories Inc
0 catalysts
Phase 2
meningococcal (pentavalent) vaccine
MenPenta
Neisseria meningitidis Infections
$SNYSanofi
0 catalysts
← prev
page 20 of 24
next →
131
Pain89
Neurology1
Phase 3
meningococcal [serotype B] vaccine
Bexsero
Neisseria meningitidis Infections
Neisserial heparin binding antigen
$GSKGSK plc
0 catalysts
Marketed
meningococcal [serotype C] vaccine
Menomune-C
Neisseria meningitidis Infections
Sanofi Pasteur Inc
0 catalysts
Marketed
meningococcal [serotypes A, B, C, W-135, Y] vaccine
Penmenvy
Neisseria meningitidis Infections
GlaxoSmithKline LLC
0 catalysts
Marketed
meningococcal [serotypes A, C, W-135, Y] vaccine
Menveo
Neisseria meningitidis Infections
GlaxoSmithKline LLC
0 catalysts
Marketed
meningococcal [serotypes A, C, W-135, Y] vaccine (Menactra)
Menactra
Neisseria meningitidis Infections
Sanofi Pasteur Inc
0 catalysts
Phase 2
meplazumab
Ketantin
Malaria
Jiangsu Pacific Meinuoke Bio-Pharmarceutical Co Ltd
0 catalysts
Phase 1
meropenem + pilabactam
meropenem [INN] + pilabactam [INN]
Acinetobacter Infections
Antabio SAS
0 catalysts
Marketed
miconazole nitrate
Monistat 7 (miconazole nitrate)
Vulvovaginal Candidiasis
Insight Pharmaceuticals LLC
0 catalysts
Marketed
miltefosine
Impavido (miltefosine [INN])
Visceral Leishmaniasis (Kala-Azar)
Profounda Inc
0 catalysts
Phase 2
mosedipimod
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Enzychem Lifesciences Corp
0 catalysts
Phase 2
moxidectin
Moxidectin (moxidectin)
Scabies
Atticus Medical Pty Ltd
0 catalysts
Marketed
mupirocin calcium
Mupirocin Calcium (mupirocin calcium)
Impetigo
Amneal Pharmaceuticals of New York LLC
0 catalysts
Phase 1
nafamostat mesylate
Coronavirus Disease 2019 (COVID-19)
$ENSCEnsysce Biosciences, Inc.
0 catalysts
Marketed
nafcillin sodium
Nafcillin Sodium (nafcillin sodium)
Bacterial Endocarditis
Claris Lifesciences Inc
0 catalysts
Marketed
naftifine hydrochloride
Naftin (naftifine hydrochloride)
Tinea Corporis
Legacy Pharma Solutions
0 catalysts
Marketed
nelfinavir mesylate
Viracept (nelfinavir mesylate)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
$PFEPFIZER INC
0 catalysts
Marketed
nevirapine
Nevirapine (nevirapine)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Camber Pharmaceuticals Inc
0 catalysts
Marketed
nifurtimox
Lampit (nifurtimox [INN])
Chagas Disease (American Trypanosomiasis)
Bayer HealthCare Pharmaceuticals Inc
0 catalysts
pre_registration
nirmatrelvir + ritonavir
Paxlovid (nirmatrelvir + ritonavir)
Coronavirus Disease 2019 (COVID-19)
$PFEPFIZER INC
0 catalysts
Phase 1
nitazoxanide
Alinia (nitazoxanide)
Acute On Chronic Liver Failure (ACLF)
Genfit SA
0 catalysts
Phase 1
norovirus [strain GI.1] vaccine
Norovirus Infections
$VXRTVaxart, Inc.
0 catalysts
Marketed
nystatin
Nystatin (nystatin [INN])
Chronic Mucocutaneous Candidiasis
Actavis Mid Atlantic LLC
0 catalysts
Marketed
obiltoxaximab
Anthim (obiltoxaximab)
Anthrax
Elusys Therapeutics Inc
0 catalysts
Marketed
omadacycline tosylate
Nuzyra (omadacycline tosylate)
Mycobacterium Infections
Bacterial 70S ribosome
Paratek Pharmaceuticals Inc
0 catalysts
Marketed
oritavancin diphosphate
Orbactiv (oritavancin diphosphate)
Skin And Skin Structure Infections (SSSI) Caused By Bacteria
A. Menarini Industrie Farmaceutiche Riunite Srl
0 catalysts
Marketed
oteseconazole
Vivjoa (oteseconazole)
Onychomycosis (Tinea Unguium)
Lanosterol 14-alpha demethylase
Mycovia Pharmaceuticals Inc
0 catalysts
Marketed
oxacillin
Bactocill (oxacillin [INN])
Staphylococcal Infections
Baxter Healthcare Corp
0 catalysts